ARCT: Arcturus Therapeutics Holdings Inc
ARCT exchange rate has changed by -1.93% for today. During the day, the instrument was traded at a low of 6.95 and at a high of 7.21.
Follow Arcturus Therapeutics Holdings Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ARCT News
- Arcturus Therapeutics: Downgrading to "Hold" As CF Program Shifts Population Focus (ARCT)
- Arcturus Therapeutics Holdings Inc. (ARCT) Q4 2025 Earnings Call Transcript
- Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates
- Arcturus Therapeutics falls 5% on weak quarterly revenue
- Arcturus Therapeutics Holdings Inc earnings missed by $5.31, revenue fell short of estimates
- Compugen (CGEN) Beats Q4 Earnings and Revenue Estimates
- Fate Therapeutics (FATE) Reports Q4 Loss, Misses Revenue Estimates
- Arcturus at Guggenheim Biotech Summit: Strategic Advances in mRNA Therapies
- Roth/MKM initiates coverage on Arcturus Therapeutics stock with Buy rating
- Cathie Wood Raises Bets on Baidu and WeRide, Sheds Tesla - TipRanks.com
- ARCT Stock Plunges 59% in Three Months: Here's What You Need to Know
- Arcturus Therapeutics Holdings Inc. (ARCT) Q3 2025 Earnings Call Transcript
- Arcturus Therapeutics (ARCT) Reports Q3 Loss, Beats Revenue Estimates
- Arcturus Therapeutics Holdings Inc earnings missed by $6.02, revenue fell short of estimates
- Sangamo Therapeutics (SGMO) Reports Q3 Loss, Lags Revenue Estimates
- Fate Therapeutics (FATE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
- Earnings Preview: Arcturus Therapeutics (ARCT) Q3 Earnings Expected to Decline
- NeoGenomics (NEO) Surpasses Q3 Earnings and Revenue Estimates
- Cathie Wood Trims Exposure to AMD and Other U.S. Tech Favorites, Doubles Down on Baidu and Biotech Plays - TipRanks.com
- H.C. Wainwright downgrades Arcturus Therapeutics stock rating on CF program concerns
- This Molina Healthcare Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday - Torrid Holdings (NYSE:CURV), Arcturus Therapeutics (NASDAQ:ARCT)
Frequently Asked Questions
What is ARCT stock price today?
Arcturus Therapeutics Holdings Inc stock is priced at 7.11 today. It trades within 6.95 - 7.21, yesterday's close was 7.25, and trading volume reached 919. The live price chart of ARCT shows these updates.
Does Arcturus Therapeutics Holdings Inc stock pay dividends?
Arcturus Therapeutics Holdings Inc is currently valued at 7.11. Dividend policy depends on the company, while investors also watch -32.22% and USD. View the chart live to track ARCT movements.
How to buy ARCT stock?
You can buy Arcturus Therapeutics Holdings Inc shares at the current price of 7.11. Orders are usually placed near 7.11 or 7.41, while 919 and 1.43% show market activity. Follow ARCT updates on the live chart today.
How to invest into ARCT stock?
Investing in Arcturus Therapeutics Holdings Inc involves considering the yearly range 5.86 - 24.14 and current price 7.11. Many compare -10.68% and -63.10% before placing orders at 7.11 or 7.41. Explore the ARCT price chart live with daily changes.
What are Arcturus Therapeutics Holdings Inc stock highest prices?
The highest price of Arcturus Therapeutics Holdings Inc in the past year was 24.14. Within 5.86 - 24.14, the stock fluctuated notably, and comparing with 7.25 helps spot resistance levels. Track Arcturus Therapeutics Holdings Inc performance using the live chart.
What are Arcturus Therapeutics Holdings Inc stock lowest prices?
The lowest price of Arcturus Therapeutics Holdings Inc (ARCT) over the year was 5.86. Comparing it with the current 7.11 and 5.86 - 24.14 shows potential long-term entry points. Watch ARCT moves on the chart live for more details.
When did ARCT stock split?
Arcturus Therapeutics Holdings Inc has gone through stock splits historically. These changes are visible in , 7.25, and -32.22% after corporate actions.
- Previous Close
- 7.25
- Open
- 7.01
- Bid
- 7.11
- Ask
- 7.41
- Low
- 6.95
- High
- 7.21
- Volume
- 919
- Daily Change
- -1.93%
- Month Change
- -10.68%
- 6 Months Change
- -63.10%
- Year Change
- -32.22%